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A patient with postvascular graft placement presented with bacteremia but no localizing symptoms. Our standard
infected graft workup of computed tomography (CT) scan, ultrasound scan, magnetic resonance imaging (MRI) scan,
and additional laboratory tests did not localize the infection source. Nuclear medicine had three options including white
blood cell (WBC) scan, gallium scan, and the fluorine-18-fluorodeoxyglucose positron emission tomography (FDG-
PET)/CT scan. FDG-PET/CT imaging alone demonstrated the location. We present an unusual case of Mycobacterium
abscessus in a vascular graft not localized with CT scan, ultrasound scan, or MRI scan and could only be localized with
FDG-PET/CT scan. (J Vasc Surg 2009;50:907-9.)The reported incidence of vascular bypass graft infec-
tion varies from 1% to 6%. Most cases involve gram-positive
cocci-like Staphylococcus epidermidis and aureus.1-5 It is
easy to recognize a graft infection when localizing symp-
toms (ie, warmth, swelling, pain, or drainage) are present.
However, the diagnosis can be challenging with only non-
specific signs and symptoms (ie, elevated white blood cell
[WBC] count, C-reactive protein or erythrocyte sedimen-
tation rate, or bacteremia). Computed tomography (CT)
scans have long been considered the best confirmatory test
of graft infection.6 We report a case of a femoral-to-
popliteal polytetrafluoroethylene (Gore-Tex; W. L. Gore
& Associates, Inc, Elkton, Md) bypass graft infection
by Mycobacterium abscessus localized only by fluorine-
18-fluorodeoxyglucose positron emission tomography/
computed tomography (FDG-PET/CT).
CASE REPORT
A 75-year-old female with type 2 diabetes mellitus, chronic
renal failure, hypertension, and peripheral vascular disease was
admitted to the hospital for a nonhealing foot ulcer with suspected
underlying osteomyelitis. The vascular evaluation revealed left
superficial femoral artery occlusion at its origin with reconstitution
of flow in themid to distal superficial femoral artery. There were no
veins available for lower extremity bypass.
Ultimately, the patient underwent a left femoral-to-popliteal
Gore-Tex bypass graft. Postoperatively, the patient required mul-
tiple hospital admissions for systemic illness, including bowel ob-
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cular bypass procedure, she developed swelling, pain, and patchy
erythema of her left leg from the foot to the thigh. Suspicion arose
of an infected prosthetic graft, but a Doppler/duplex scan graft
study showed a patent vascular graft unchanged from previous
studies, as well as normal venous compressibility and augmentation
response. The patient continued to have edema in her operative leg
with subsequent development of erythema and pain. A repeat sono-
graphic bypass study showed no change from the previous exams. A
screening noncontrast and contrast-enhanced magnetic resonance
imaging (MRI) scan of the postoperative leg from the thigh to the
foot showed widespread soft tissue andmuscle edema consistent with
nonspecific cellulitis/myositis, but no signs of osteomyelitis or bypass
graft infection (Fig 1). In order to rule out myositis andmyonecrosis,
which the widespread edema suggested, a quadriceps femoris muscle
biopsy was done that showed no inflammation.
A nuclear medicine consult suggested three possible studies
that might help in identifying a suspected infection: In-111
oxyquinoline (Indium-Oxine; GE Healthcare and Amersham Bio-
sciences, Pittsburgh, Pa) or Tc-99m hexamethylpropyleneamine
oxime (HMPAO; GE Healthcare and Amersham Biosciences)
labeled white blood cell (WBC), gallium-67 citrate (Mallinckrodt
Inc, Maryland Heights, Mo), and fluorine-18-fluorodeoxyglucose
positron emission tomography (FDG-PET/CT) scan. The highest
resolution and fastest turnaround in our rural community was the
FDG-PET/CT scan. When the patient failed to improve, an
FDG-PET/CT scan was ordered to re-evaluate the source of her
infection,which localized increased abnormal activity overlying 18 cm
of the bypass graft with a standardized uptake value (SUV) of 4.9 (Fig
2). Blood cultures eventually grewMycobacterium abscessus.
The prosthetic graft was resected and reconstruction was
performed utilizing an arm vein. The graft was covered with a
severe inflammatory reaction, but there was no fluid or purulence.
The patient was treated systemically with clarithromycin and mi-
nocycline for 9 months with a plan for a total of 12 months.
Cultures from the explanted graft grew the same Mycobacterium
abscessus as the blood cultures. There were no postoperative com-
plications and she recovered fully.
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Prosthetic vascular grafts for bypass procedures have
been successfully employed for decades. Known complica-
tions include infection, material deterioration, erosion or
fistulization, anastomotic aneurysm, and occlusion.7 Fur-
thermore, amputation rates up to 70% and cumulative
mortality rates ranging from 25% up to 88% are seen after
prosthetic vascular graft infection.1,2,8,9 The causative or-
ganisms for infection are most commonly reported as
Staphylococcus aureus and coagulase-negative staphylo-
cocci, although in as many as 25% of cases, the causative
organism is never identified.10,11 To the best of our knowl-
edge and literature review, there have been no previous
reports of prosthetic vascular graft infections due to Myco-
bacterium abscessus.
Mycobacterium abscessus is one of the rapidly growing
mycobacteria that grow on agar media within 7 days. It is
found worldwide and rapidly recovered from soil, plants,
animal and bird materials, and both natural and treated
water. Mycobacterium abscessus causes disease in both nor-
mal and immunocompromised hosts. Although uncom-
mon, there have been case reports of postoperative surgical
infections and prosthetic device infections.
The continuous bacteremia over several days suggested
an endovascular infection and the prosthetic graft was
suspect. The PET/CT imaging scan was helpful in con-
firming this impression. The patient eventually did well
following graft removal and prolonged parenteral and oral
antibiotics.
We report the Mycobacterium abscessus infection of an
infrainguinal vascular bypass prosthetic graft localized by
Fig 1. Transaxial magnetic resonance short tau inversion recov-
ery image shows extensive inflammatory changes in the subcuta-
neous tissues but no graft infarction and a patent graft.FDG-PET/CT scan. Historically, CT scans are reported asthe principal means of distinguishing graft infection from
other infectious diseases.6 Our patient had a Doppler ultra-
sound scan as well as an MRI scan of her extremity, both of
which did not reveal localizing signs of infection or com-
promise of the bypass graft. A CT scan was not performed
because of the patient’s chronic renal failure. Once bacte-
remia was detected, localization of the source of the pa-
tient’s infection was identified only by FDG-PET/CT scan.
Mycobacteria elicit a secondary immune response which
may explain the lack of fluid around the graft. Several
studies suggest FDG-PET/CT scans can assess the location
and extent of infection more accurately than conventional
imaging modalities, especially when infection symptoms
are nonlocalizing.12-19 The most recent literature reports
the sensitivity and specificity of PET for arterial prosthetic
graft infection at 91% and 95%, respectively.20
FDG-PET/CT scan studies have not been approved
for reimbursement by Centers for Medicare & Medicaid
Services (CMS) yet. Most people working with PET/CT
scans feel it is far superior to other older radionuclide
studies. Presently, there are two ways to have the study
Fig 2. The three-dimensional (3D) maximum intensity projec-
tion fluorodeoxyglucose-positron emission tomography/com-
puted tomography (FDG-PET/CT) scan images demonstrate the
location and extent of the graft infection.reimbursed: admit the patient for the infection workup and
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patients have it done under the National Oncologic PET
Registry.
CONCLUSION
Vascular prosthetic graft infections are a rare but po-
tentially devastating complication. The diagnosis should be
suspected on the history and physical findings with the
appropriate confirmatory tests. Atypical infections may not
present with the usual signs of graft infection. An FDG-
PET/CT scan can be useful in confirming the presence and
location of a graft infection, especially when conventional
imaging fails to localize the source of infection.
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